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Echinococcus multilocularis (E. multilocularis), is a very
aggressive and potentially fatal infestation which affects pri-
marily the liver and can metastasize to any part of the body
through hematogenous spread. It displays a prolonged latency
period before clinical presentation, behaving like a slow-
growing liver cancer with subsequent invasion of liver tissues
and metastatic dissemination. The disease produces liver ne-
crosis invading not only the hepatic and biliary tissues, but also
the vessels of the liver, inferior vena cava, and diaphragm.
Surgical resection of the parasite at an early stage of infection
may provide favorable prospects for cure, but due to the long
clinical latency, many cases are diagnosed at an advanced stage,
so that partial liver resection can be performed in only 40% of
patients [1]. Live-donor liver transplantation (LT) can provide
patients with advanced-stage (AE), the best chance for long term
disease-free and overall survival [1,2]. We herein report a case of
hepatic echinococcosis who successfully underwent live-donor
LT in our institution.
A 31-year-old female from Kyrgyzstan came to our center
with complaints of vague discomfort and right upper quadrant
abdominal pain since one year which increased since last two
months with history of anorexia, weight loss and jaundice. On
physical examination, her vital signs were within normal limits
with yellowish discoloration of skin and visible mucosa. On
examination of the abdomen, the liver was enlarged up to12 cm
below right costal margin with ﬁrm and irregular surface. Lab-
oratory biochemical analysis revealed total bilirubin, direct
bilirubin, serum aspartate aminotransferase, alanine amino-
transferase and alkaline phosphatase concentrations of 1.1 mg/
dL, 0.4 mg/dL, 75 U/L, 104 U/L and 1 448 U/L, respectively.
Tumor markers were found to be negative. Abdominal ultraso-
nography with doppler revealed an enlarged liver showing
heterogenous echotexture with multiple space occupying le-
sions. Many ill-deﬁned echogenic areas were seen distributed in
the right lobe of liver forming a conglomerate mass like lesion
and another echogenic space occupying lesions measuring51 mm × 65 mm in the left lobe. The right main portal vein
showed low level echoes without any uptake of color suggestive
of thrombus. Computed Tomography of the abdomen revealed a
diffusely inﬁltrative geographical hypodense lesion within the
liver parenchyma with multiple amorphous areas of calciﬁcation
almost completely replacing the left lobe of liver (Figure 1A).
Multiple other similar inﬁltrative nodular areas were seen further
in the posterior segment of the right lobe, the largest lesion
measuring 66 mm × 52 mm. This lesion was encasing, attenu-
ating and occluding the arterial, hepatic venous, the portal
venous divisions and its territory. The main portal vein at the
level of the liver hilum was signiﬁcantly occluded. In the
meanwhile, keeping the diagnosis of echinococcus in mind, a
serum sample was sent for E. multilocularis antibodies using
enzyme-linked immunosorbent assay, and serology was noted to
be positive. Based on serology and imaging studies, hepatic
Alveolar echinococcosis was diagnosed and due to extensive
liver involvement with portal vein thrombosis, live donor LT
was offered as a curative treatment choice. The patient under-
went live donor related LT. Gross examination from the
explanted liver, revealed smooth and focally bosselated external
surface with whitish areas. Nearly half of the cut surface of the
right lobe was replaced by whitish ﬁrm areas, largest measuring
105 mm × 95 mm × 80 mm, surrounding the major portal tracts
and ducts (Figure 1B). Focal areas of necrosis were identiﬁed.
Left lobe was almost completely replaced by ﬁrm areas. On
histopathological examination, extensive areas of necrosis were
seen with multiple necrotising granulomas around small, dead
and viable ectocysts with scolices (Figure 1C). Strong periodic
acid-schiff (PAS) positive ribbon like and lamellated structures
were seen (Figure 1D). Adjacent hepatocytes showed atrophy
with moderate macro and microvesicular steatosis. Sections
from gall bladder wall showed focal necrosis and granulomas.
Hepatectomy specimen was compatible with diffuse Echino-
coccus alveolaris infection. The postoperative period was un-
remarkable, and the patient was discharged from the hospital
18 d after undergoing live-donor LT. The immunosuppressivepen access article under the CC BY-NC-ND
Figure 1. A: Abdominal CT scan showing diffusely inﬁltrative geographical hypodense lesion within the liver parenchyma almost completely replacing
both lobes of liver with multiple amorphous areas of calciﬁcation; B: Macroscopic appearance of explanted liver, cut section showing whitish ﬁrm areas
along with extensive areas of necrosis, almost completely replacing both the lobes (inset: smooth and focally bosselated external surface of liver with whitish
areas); C: Microscopic examination showing extensive areas of necrosis with variable sized multilocular cystic spaces (Hematoxylin & eosin, 20×); D:
Strong PAS positive ribbon like and lamellated structures consistent with AE (20×).
Letter to editors/Asian Paciﬁc Journal of Tropical Medicine 2015; 8(8): 683–684684regimen consisted of methylprednisolone, 5 mg/kg and tacroli-
mus, 0.1 mg/kg. Albendazole 400 mg/d was also prescribed. The
patient is doing well 6 months follow-up.
Hepatic Alveolar echinococcosis is a rare slow growing tu-
mor like lesion, primarily involving liver and has a potential to
inﬁltrate adjacent organs and distant sites as brain, lungs through
hematogenous spread. It is a rare cause of LT. Correct and
timely diagnosis of the hepatic AE will allow for appropriate
treatment and thereby improving overall survival. Abdominal
ultrasonography is the ﬁrst-line imaging modality for evaluation
of patients, in whom AE is suspected and is also used to monitor
efﬁcacy of medical therapy [3]. CT is always performed because
it has a high sensitivity (94%) [4]. Radical surgery is
recommended for treatment, whenever feasible in early stage
AE. Living donor or cadaver donor liver transplantation
should be considered in the management of advanced hepatic
alveolar echinococcosis. However, surgical procedures and
radiologic interventions which are directed toward treating
complications may pose technical difﬁculties for future liver
transplantation [1]. Therefore, in patients with symptomatic and
advanced disease, liver transplantation should be considered as
a preferred treatment option. Extrahepatic invasion by the
lesion must be carefully sought during the preoperative period.
In addition, the dosages of immunosuppression medications
should be kept at low levels, and medical therapy must be
administered before and after surgery. Even after the LT, for
most patients this is still a chronic disease requiring long-term,
mostly lifelong chemotherapy under medical supervision. Thepossibility of ongoing disease must be kept in mind. Regular
follow-up of patients should include a systematic radiological
evaluation, monitoring of anti–E. multilocularis by enzyme-
linked immunosorbent assay for assessment of disease status
and evaluation of drug side effects.
To conclude, we report a case of hepatic echinococcosis
which successfully underwent live-donor LT. It is therefore a
feasible option in end-stage cases that are considered intractable.
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